Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haley Newman

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Pediatric Blood & Cancer|July 13, 2024
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trialsJamie Shoag, Yimei Li, Kelly D Getz, et al.
Blood Advances|September 18, 2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patientsMatthew R Schuelke, Hamid Bassiri, Edward M Behrens, et al.
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
Hemasphere|April 10, 2026
Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patientsCaroline Diorio, Regina M Myers, Yimei Li, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
Blood|May 13, 2022
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALLCaroline Diorio, Ryan Murray, Mark Naniong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Haematologica|February 22, 2024
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly <i>versus</i> paired tumor-normal sequencingHaley Newman, Mary Egan Clark, Derek Wong, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.
Pediatric Blood & Cancer|July 13, 2024
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trialsJamie Shoag, Yimei Li, Kelly D Getz, et al.
Blood Advances|September 18, 2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patientsMatthew R Schuelke, Hamid Bassiri, Edward M Behrens, et al.
Haematologica|January 30, 2025
Integrated genomic analysis to reduce chromosomal analysis for the diagnosis of pediatric hematologic malignancies: addressing the shortage of cytogenetic technologistsDong Li, Sarah K Tasian, Gerald Wertheim, et al.
Hemasphere|April 10, 2026
Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patientsCaroline Diorio, Regina M Myers, Yimei Li, et al.
Blood|November 9, 2022
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapyHaley Newman, Yimei Li, Hongyan Liu, et al.
Blood|May 13, 2022
Cytosine base editing enables quadruple-edited allogeneic CART cells for T-ALLCaroline Diorio, Ryan Murray, Mark Naniong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2022
Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19Caroline Diorio, Rawan Shraim, Regina Myers, et al.
Cancer Medicine|April 4, 2024
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity researchHaley Newman, Yimei Li, Yuan-Shung V Huang, et al.
Haematologica|February 22, 2024
Genomic profiling of pediatric hematologic malignancies and diagnosis of cancer predisposition syndromes: tumoronly <i>versus</i> paired tumor-normal sequencingHaley Newman, Mary Egan Clark, Derek Wong, et al.
Pageof 5